PLURI INC.

Profile

Company Names

PLURI INC.
PLURISTEM THERAPEUTICS INC

Addresses

MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, L3 3508409

MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 20, HAIFA, L3 31905

Phone Numbers

972-74-710-7171
011-972-74-7107171

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$13,439,326.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-02-03 
$3,500,000.00 
$3,500,000.00 
$0.00 
Equity 
3
2022-12-13 
$8,469,323.00 
$8,469,323.00 
$0.00 
Equity 
2
2010-10-12 
$1,220,003.00 
$1,220,003.00 
$0.00 
Equity 
1
2010-04-26 
$250,000.00 
$250,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ZAMI 
 
ABERMAN 
DIRECTOR, EXECUTIVE OFFICER
PLURISTEM THERAPEUTICS INC   |  PLURI INC.
ISRAEL 
 
BEN-YORAM 
DIRECTOR
PLURISTEM THERAPEUTICS INC
DORON 
 
BIRGER 
DIRECTOR
ICECURE MEDICAL LTD.   |  MEDIGUS LTD.   |  PLURI INC.
ISAAC 
 
BRAUN 
DIRECTOR
PLURISTEM THERAPEUTICS INC
CHEN 
 
FRANCO-YEHUDA 
EXECUTIVE OFFICER
PLURI INC.   |  BRENMILLER ENERGY LTD.   |  DARIOHEALTH CORP.
MARK 
 
GERMAIN 
DIRECTOR
PLURISTEM THERAPEUTICS INC   |  18 SQUARED TACTICAL FUND, LP   |  SCINAI IMMUNOTHERAPEUTICS LTD.
RAMI 
 
LEVI 
DIRECTOR
PLURI INC.
HAVA 
 
MERETZKI 
DIRECTOR
PLURISTEM THERAPEUTICS INC
SHAI 
 
PINES 
DIRECTOR
PLURISTEM THERAPEUTICS INC
NACHUM 
 
ROSMAN 
DIRECTOR
PLURISTEM THERAPEUTICS INC
VARDA 
 
SHALEV 
DIRECTOR
PLURI INC.
MAITAL 
 
SHEMESH-RAMUSSEN 
DIRECTOR
PLURI INC.
MAITAL 
 
SHEMESH-RASMUSSEN 
DIRECTOR
PLURI INC.
DORON 
 
SHORRER 
DIRECTOR
PLURISTEM THERAPEUTICS INC
ALEJANDRO 
 
WEINSTEIN 
DIRECTOR
HPH SPECIALIZED FUND 1, L.P.   |  HPH II INVESTMENTS MASTER FUND, LP   |  HPH III INVESTMENTS, LP   |  HPH III INVESTMENTS PARALLEL FUND, LP   |  HPH III OFFSHORE PARALLEL FUND, LP   |  HPH III INVESTMENTS PARALLEL FUND A, LP   |  PLURI INC.
YAKY 
 
YANAY 
EXECUTIVE OFFICER, DIRECTOR
PLURISTEM THERAPEUTICS INC   |  PLURI INC.
LIAT 
 
ZALTS 
EXECUTIVE OFFICER
PLURI INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-03-19
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-02-03 
2022-12-30
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2022-12-13 
2010-10-14
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2010-10-12 
2010-05-11
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2010-04-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NONE
NONE
NONE
NONE
RODMAN + RENSHAW, LLC
16415